´╗┐
 Return to QS12 Overview

Breast Cancer [QS12]

Measuring the use of this guidance

Statement: 1

People with suspected breast cancer referred to specialist services are offered the triple diagnostic assessment in a single hospital visit. [new 2016]

Quality standard measure: Proportion of people with suspected breast cancer referred to specialist services who receive the triple diagnostic assessment in a single visit.
What was measured: Proportion of women aged 50 and over with non-screen detected early invasive breast cancer who received triple diagnostic assessment in a single visit.
Data collection end: December 2016
29%
Area covered: England and Wales
Source: The Royal College of Surgeons. National Audit of Breast Cancer in Older Patients.


Statement: 4

People with newly diagnosed invasive breast cancer and those with recurrent breast cancer (if clinically appropriate) have the oestrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status of the tumour assessed. [2011, updated 2016]

Quality standard measure: Proportion of people with newly diagnosed invasive breast cancer who have the ER status of the tumour assessed.
What was measured: Proportion of women aged 50 and over diagnosed with invasive breast cancer who have ER status recorded.
Data collection end: December 2016
86%
Area covered: England and Wales
Source: The Royal College of Surgeons. National Audit of Breast Cancer in Older Patients.

Quality standard measure: Proportion of people with newly diagnosed invasive breast cancer who have the HER2 status of the tumour assessed.
What was measured: Proportion of women aged 50 and over diagnosed with invasive breast cancer who have HER2 status recorded.
Data collection end: December 2016
82%
Area covered: England and Wales
Source: The Royal College of Surgeons. National Audit of Breast Cancer in Older Patients.


Statement: 6

People with locally advanced, metastatic or distant recurrent breast cancer are assigned a key worker. [2011, updated 2016]

Quality standard measure: Patient satisfaction with information and support received throughout their care for breast cancer.
What was measured: Proportion of breast cancer patients who reported being given the name of a Clinical Nurse Specialist who would support them through their treatment.
Data collection end: June 2015
94.4%
Data collection end: June 2016
94.4%
Data collection end: June 2017
94.7%
Data collection end: June 2018
94.5%
Area covered: England
Source: Quality Health. National Cancer Patient Experience Survey.

Quality standard measure: Patient satisfaction with information and support received throughout their care for breast cancer.
What was measured: Proportion of breast cancer patients who reported finding it easy to contact their Clinical Nurse Specialist.
Data collection end: June 2015
85.3%
Data collection end: June 2016
85.9%
Data collection end: June 2017
85.9%
Data collection end: June 2018
84.9%
Area covered: England
Source: Quality Health. National Cancer Patient Experience Survey.

Quality standard measure: Patient satisfaction with information and support received throughout their care for breast cancer.
What was measured: Proportion of breast cancer patients who reported that, when they had important questions to ask a Clinical Nurse Specialist, they got answers they could understand all or most of the time.
Data collection end: June 2015
88.3%
Data collection end: June 2016
88.6%
Data collection end: June 2017
88.2%
Data collection end: June 2018
88%
Area covered: England
Source: Quality Health. National Cancer Patient Experience Survey.

Quality standard measure: Evidence of local arrangements to ensure that people with locally advanced, metastatic or distant recurrent breast cancer are assigned a key worker.
What was measured: In England, the proportion of women with breast cancer who had contact with a clinical nurse specialist.
Data collection end: July 2018
95%
Area covered: England and Wales
Source: Royal College of Surgeons. National Audit of Breast Cancer in Older Patients.

View quality statement history

Archived quality statements

Quality statements that are no longer current have been archived.

View archived quality statements

 Return to QS12 Overview